Observed arrival · 2026-11-06
Cancer Signaling Atlas connects pathways to drug targets
An interactive oncology reference links ten cancer-signaling pathways, sixteen explainer episodes, and 102 drug targets and antigens.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Cancer biology learners and oncology teams
- Worth noticing
- The page says FDA approval status was reviewed in November 2026 and cautions that status may differ by country.
Field notes
The target explorer organizes entries by modality, approval status, and episode, and the page says each row links back to its pathway and the episode that explains it. Its KRAS G12C example names sotorasib and adagrasib and points to papers and FDA material. The site labels approval status as current through November 2026 and notes that it may vary by country.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
⊠LoginAccess appeared gated
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue